世卫组织现已将双氢青蒿素加上哌喹作为第五个青蒿素为基础的联合疗法，添加到以往建议的药品清单中。
WHO has now added a fifth ACT - dihydroartemisinin plus piperaquine - to the previous list of recommended medicines.
目的：探讨双氢青蒿素哌喹片在柬埔寨马德望省治疗无并发症恶性疟的有效性和安全性。
AIM: To explore the effect and safety of dihydroartemisinin piperaquine(DP) phosphate tablet in treatment of uncomplicated falciparum malaria in battambang of Combodia.
目的 观察双氢青蒿素哌喹复方片对缅甸无并发症恶性疟的疗效。
Objective To observe the therapeutic efficacy of compound dihydroartemisinin-piperaquine for treatment of uncomplicated falciparum malaria in Myanmar.
应用推荐